Most Read Articles
2 days ago
No association exists between physical activity and the risk of urological cancer, according to a population-based prospective study in Japan.
12 Feb 2019
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
3 days ago
Patients with childhood-onset inflammatory bowel disease are more likely to die than the general population, a study suggests.
3 days ago
Reduced caloric intake results in a significant improvement in glucose metabolism and body-fat composition, including liver-fat content, according to a study. Changes in ferritin levels appear to mediate the striking reduction in liver fat.

Endoscopic injection of dextranomer/hyaluronic acid safe, effective in high-grade vesicoureteral reflux

08 Sep 2018

A recent study has shown the efficiency and safety of endoscopic injection of dextranomer/hyaluronic acid as long-term treatment for grade IV and V vesicoureteral reflux. Moreover, it can easily be repeated in patients with treatment failure with a high subsequent resolution rate.

Overall, there was a 69.5-percent resolution rate after the first endoscopic injection (70.4 percent and 61.9 percent of grade IV and V cases, respectively). Reflux resolved in 259 (20.1 percent) and 133 (10.4 percent) patients after a second and third injection, respectively.

Patients aged <1 year and those with renal scarring were at higher odds of persistent reflux after initial treatment. There were no significant postoperative complications, and no patient needed ureteral reimplantation.

Febrile urinary tract infection occurred in 43 children (5.1 percent) after reflux resolution, including 24 (55.8 percent) during the first year, 15 (34.9 percent) during the second year and four (9.3 percent) during year 3 or later. Of these, six had reflux recurrence and eight had neocontralateral grade III reflux, which was resolved with a single endoscopic injection of dextranomer/hyaluronic acid.

The study included 518 girls and 333 boys (median age 2.3 years; range, 2 months to 13.7 years) who underwent endoscopic correction of high-grade vesicoureteral reflux using dextranomer/hyaluronic acid. Reflux was unilateral and bilateral in 415 and 436 patients, respectively, comprising 1,287 refluxing units. Reflux was grade IV and V in 1,153 (89.6 percent) and 134 (10.4 percent) ureters, respectively.

Renal scarring was identified in 317 patients (37.3 percent) using 99mtechnetium-dimercaptosuccinic acid scintigraphy. Follow-up ultrasound and voiding cystourethrogram were conducted 3 months after intervention and renal ultrasound yearly afterwards. Median follow-up was 8.5 years (range, 6 months to 16 years).

Editor's Recommendations
Most Read Articles
2 days ago
No association exists between physical activity and the risk of urological cancer, according to a population-based prospective study in Japan.
12 Feb 2019
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
3 days ago
Patients with childhood-onset inflammatory bowel disease are more likely to die than the general population, a study suggests.
3 days ago
Reduced caloric intake results in a significant improvement in glucose metabolism and body-fat composition, including liver-fat content, according to a study. Changes in ferritin levels appear to mediate the striking reduction in liver fat.